Hasil Pencarian  ::  Simpan CSV :: Kembali

"Latar belakang: Telah dilaporkan bahwa terdapat perubahan pada ekspresi dari ribuan gen di jaringan endometrium endometriosis, termasuk diantaranya adalah gen FN1 dan RAC1. Perubahan ekspresi gen tersebut dapat disebabkan oleh mekanisme epigenetik seperti perubahan tingkat metilasi DNA pada gen.Tujuan: Mengetahui tingkat metilasi DNA pada gen FN1 dan RAC1 serta ekspresi mRNAnya pada jaringan endometrium subjek endometriosis dan nir-endometriosis.Metode: Penelitian ini merupakan cross sectional dengan jumlah sampel sebanyak 40 dari jaringan endometrium subjek endometriosis dan subjek nir-endometriosis. Sampel diambil dengan teknik mikrokuretase di RSUPN Ciptomangunkusumo dan RS Fatmawati Jakarta. Pada jaringan kemudian dilakukan isolasi DNA dan RNA. Pada isolat DNA dilakukan konversi bisulfit, MSP, elektroforesis dan analisis intensitas pita menggunakan software ImageJ untuk mendapatkan data persentase tingkat metilasi DNA. Pada isolat RNA dilakukan qRT-PCR untuk mendapatkan ekspresi relatif mRNA gen FN1 dan RAC1.Hasil: Analisis persentase tingkat metilasi DNA promotor menunjukkan terdapat perbedaan bermakna (p=0,022) pada gen FN1 pada pasien endometriosis (37,95%) dibandingkan nir-endometriosis (59,22 %), sedangkan pada gen RAC1 tidak terdapat perbedaan bermakna (p=0,63) dengan tingkat metilasi subjek endometriosis (28.45%) dan subjek nir-endometriosis (26.11%). Penelitian ini juga melaporkan terjadinya peningkatan ekspresi relatif mRNA gen FN1 dan RAC1 dibandingkan dengan subjek nir-endometriosis, namun secara statistik tidak terdapat perbedaan bermakna (p>0,05). Tidak terdapat korelasi bermakna antara tingkat metilasi gen FN1 dan RAC1 dengan ekspresi mRNAnya.Kesimpulan: Terjadi penurunan tingkat metilasi yang bermakna pada gen FN1 di jaringan endometrium endometriosis, namun tidak berkorelasi dengan peningkatan mRNA nya. Tidak terdapat perbedaan bermakna tingkat metilasi dan ekspresi mRNA pada gen RAC1 di jaringan endometrium subjek endometriosis dibandingkan dengan nir endometriosis.

---

It has been reported that there was a changes in the expression of thousands of genes in endometrial endometriosis tissues, including the FN1 and RAC1 genes. Changes in gene expression can be caused by epigenetic mechanisms such as DNA methylation in genes.

Objective: To determine the level of DNA methylation in FN1 and RAC1 genes and their mRNA expression in endometrial tissue of endometriosis and non-ndometriosis.

Method: This study was designed as cross sectional with a total sample of 40 of endometrial tissues in the subject of endometriosis and non-endometriosis. Samples were taken by microcuretase at Ciptomangunkusumo and Fatmawati Hospital, Jakarta. DNA and RNA was isolated. DNA isolates were converted by bisulfite procedure, MSP conversion, electrophoresis, analyzed intensity of the band which appeared on gel electrophoresis using ImageJ software to obtain the percentage data of DNA methylation level. In RNA isolates, it was analyzed using qRT-PCR methode to obtain the relative mRNA expression level.

Results: Analysis of percentage of DNA methylation level showed significant differences (p=0.022) in the FN1 gene (37.95%) compared to non-endometriosis (59.22%), whereas in the RAC1 gene there was no significant difference (p=0,63) with methylation level of endometriosis subjects (28.45%) and non-endometriosis subjects (26.11%). For relative mRNA expression of FN1 and RAC1 genes showed no significant differences (p> 0.05). For correlation in endometrial endometriosis showed no significant between the rate of methylation of the FN1 and RAC1 genes with their mRNA expression.

Conclusion: There was a significant decrease in DNA methylation level of FN1 gene in endometrial endometriosis tissues, but it did not correlate with the increasing in its mRNA expression. There was no significant difference in DNA methylation level and mRNA expression of RAC1 gene in endometrial tissues of endometriosis subjects compared to non-endometriosis."

"LATAR BELAKANG: Endometriosis merupakan penyakit ginekologis kronis yang ditandai dengan adanya jaringan mirip endometrium diluar rongga uterus. Endometriosis merupakan penyebab infertilitas dan nyeri pelvik paling umum dan memengaruhi 1 dari 10 wanita usia reproduktif. Progesteron memiliki peran yang penting dalam uterus yaitu mengontrol proliferasi dan diferensiasi. Disregulasi progesteron dapat menyebabkan gangguan fungsi uterus. Resistensi progesteron banyak ditemukan pada endometriosis dan dikaitkan dengan kadar PGR yang rendah. PGR memiliki dua isoform yaitu PGR-A dan PGR-B. Hingga saat ini masih banyak pendapat yang berbeda mengenai ekspresi isoform PGR-A dan B pada endometriosis. Hipermetilasi pada daerah promotor suatu gen diyakini sebagai salah satu penyebab gene silencing yang berakibat rendahnya kadar gen tersebut. Penelitian ini bertujuan untuk mengetahui pengaruh faktor epigenetik pada reseptor hormon progesteron pada jaringan endometriosis.METODE: Penelitian ini merupakan studi kasus kontrol yang membandingkan 20 wanita penderita endometriosis dan 20 wanita bukan penderita endometriosis. Analisis metilasi DNA dilakukan dengan metode MSP dan ekspresi mRNA dengan metode qPCR. Analisis statistik yang dilakukan adalah uji t tidak berpasangan, uji Mann Whitney, uji korelasi Pearson, uji korelasi Spearman?s Rho, Uji Annova One Way dan Uji Kruskal-wallis dengan kemaknaan p<0.05.HASIL: Hasil penelitian menunjukkan bahwa tingkat metilasi pada wanita dengan endometriosis (98,72%) secara signifikan lebih tinggi dibandingkan dengan kontrol (3,74%) dengan p=0,000. Selain itu, terjadi penurunan ekspresi mRNA isoform PGR-A dan PGR-B (2,35 kali dan 6,37 kali). Terdapat korelasi antara tingkat metilasi dengan ekspresi mRNA isoform PGR-B (p=0,000; r=-0,736), namun tidak terdapat korelasi dengan ekspresi mRNA isoform PGR-A (p>0,05).KESIMPULAN: Daerah promotor gen PGR mengalami hipermetilasi pada endometriosis dibandingkan dengan kontrol dan berkaitan dengan penurunan kadar PGR-B pada endometriosis.

---

Background: Endometriosis is a chronic gynecological disorder, defined as the presence of endometrium-like tissue outside of the uterine cavity. Endometriosis is the most common causes of infertility and pelvic pain and affects 1 of 10 women in the reproductive-age group. Progesterone plays an important role in uterine. It controls endometrial proliferation and differentiation. Dysregulation of progesterone signaling leads to impaired for uterine function. Progesterone resistance has been found in endometriosis and associated with the low levels of PGR. PGR has two isoforms, PGR-A and PGR-B. Since promoter hypermethylation is associated with gene silencing, we try to determine the methylation status of PGR promoter region in endometriosis tissue using methylation spesific PCR and its association with the expression of PGR-A and PGR-B isoforms using real-time PCR.

Methods: this research is a case-control study, comparing 20 women with endometriosis and 20 women without endometriosis. Methylation status was analyzed with methylaion spesific PCR and the expression of mRNA was analyzed with real-time PCR. Statistical analyses were t-independent test, Mann Whitney test, Pearson test, Spearman?s rho test, Annova One Way test and Kruskal-Wallis test, a two-tailed p value less than 0,05 was considered significant.

Result: We found that methylation status in women with endometriosis (98,72%) was significantly higher than women without endometriosis (3,74%), statistically significant associations with the disease (p=0,000). Beside, mRNA expression of PGR-A and PGR-B isoform was down regulated (2,35 fold and 6,37 fold). Correlation between methylation status and PGR-B expression was significant (p=0,000;r=-0,736), but not PGR-A (p>0,05).

Conclusion: Promoter regions of PGR is hypermethylated in endometriosis as compared with control. This findings suggest that the promoter hypermethylation of PGR may contribute to the pathogenesis of this disease."

"Latar Belakang: Endometriosis merupakan penyakit multifaktorial yang mempengaruhi 10% wanita usia subur. Diketahui bahwa gen EGFR dan MMP-2 mengalami peningkatan ekspresi pada endometriosis sehingga memiliki peran dalam perkembangan endometriosis, dan gen yang dapat meregulasi sitoskeleton. Tujuan dari penelitian ini adalah untuk mengevaluasi hubungan antara tingkat metilasi gen EGFR dan MMP-2 dengan ekspresi mRNA-nya pada jaringan endometriosis peritoneum.Metode Penelitian: Penelitian ini menggunakan desain cross sectional. Sampel yang digunakan sebanyak 20 wanita endometriosis dan 20 wanita bukan endometriosis yang usianya sekitar 20-45 tahun. Pada wanita endometriosis diambil jaringan endometriosis peritoneum dengan tindakan laparoskopi, sedangkan 20 wanita bukan endometriosis diambil jaringan endometrium normal dengan tindakan mikrokuretase. Tingkat metilasi DNA gen EGFR dan MMP-2 dianalisis dengan metode Methylation Specific PCR (MSP) dan Ekspresi mRNA gen EGFR dan MMP-2 dianalisis dengan metode qRT-PCR.Hasil: Tingkat metilasi DNA pada gen EGFR dan MMP-2 mengalami hipermetilasi. Pada gen EGFR, tingkat metilasi DNA antara jaringan endometriosis peritoneum dibandingkan dengan jaringan endometrium normal terdapat perbedaan yang bermakna (p=0,001), sedangkan pada gen MMP-2 tingkat metilasi DNA-nya tidak terdapat perbedaan yang bermakna (p=0,596) antara jaringan endometriosis peritoneum dibandingkan dengan jaringan endometrium normal. Nilai ekspresi relatif mRNA EGFR dan MMP-2 mengalami peningkatan ekspresi pada jaringan endometriosis peritoneum. Penelitian ini tidak menunjukkan korelasi yang bermakna antara tingkat metilasi dengan tingginya ekspresi mRNA baik gen EGFR maupun MMP-2. (gen EGFR (p=0,947 dan r=-0,016) dan gen MMP-2 (p=0.769 dan r=0.070)Kesimpulan: Tingginya ekspresi mRNA EGFR dan gen MMP-2, kemungkinan bukan hanya disebabkan karena faktor metilasi DNA, melainkan faktor lainnya.

---

Background: Endometriosis is a multifactorial disease that affects 10% of women of childbearing age. It is known that the EGFR and MMP-2 genes have increased expression in endometriosis and thus have a role in the development of endometriosis, and genes that can regulate the cytoskeleton. The purpose of this study was to evaluate the relationship between the level of methylation of the EGFR and MMP-2 genes with their mRNA expression in peritoneal endometriosis tissue.

Method: The study used a cross sectional design. The sample used was 20 women with endometriosis and 20 women without endometriosis who were around 20-45 years old. In endometriosis women are taken to peritoneal endometriosis tissue by laparoscopic, while 20 women without endometriosis are taken to normal endometrial tissue by microcuretase. The levels of EGFR and MMP-2 gene methylation were analyzed by the Methylation Specific PCR (MSP) method and the mRNA expression of the EGFR and MMP-2 genes were analyzed by the qRT-PCR method.

Results: The level of DNA methylation in the EGFR and MMP-2 genes was hypermethylated. In the EGFR gene between peritoneal endometriosis tissue compared to normal endometrial tissue there were significant differences (p=0,001), whereas in the MMP-2 gene there was no significant difference (p=0.596) between peritoneal endometriosis tissue compared to normal endometrial tissue. The relative expression value of EGFR and MMP-2 mRNA has increased expression in peritoneal endometriosis tissue. This study did not show a significant correlation between the level of methylation and the high mRNA expression in both the EGFR and MMP-2 genes. (EGFR gene (p=0.947 and r=-0.016) and MMP-2 gene (p=0.769 and r=0.070)

Conclusion: The high expression of EGFR mRNA and MMP-2 gene, the possibility is not only due to hypermethylation factors, but other factors."

"Nerve Growth Factor (NGF) diketahui memiliki konsentrasi yang cenderung lebih tinggi pada wanita endometriosis dibandingkan dengan wanita tanpa endometriosis. Metilasi DNA pada daerah promotor NGF diyakini sebagai salah satu penyebab meningkatnya konsentrasi NGF pada wanita endometriosis. Penelitian ini dilakukan untuk mengetahui korelasi antara metilasi DNA dengan ekspresi mRNA NGF pada darah menstruasi wanita endometriosis. Sebanyak 10 sampel darah menstruasi dari masing-masing wanita endometriosis dan wanita tanpa endometriosis digunakan dalam penelitian ini. Tingkat metilasi DNA NGF dihitung menggunakan Methylation-specific Polymerase Chain Reaction (MSP-PCR), kemudian intensitas pita yang muncul diukur menggunakan software ImageJ. Nilai ekspresi mRNA NGF dihitung menggunakan Quantitative Real-Time Polymerase Chain Reaction (qRT PCR). Analisis korelasi, selanjutnya, dilakukan menggunakan aplikasi SPSS. Hasil penelitian menunjukkan bahwa tingkat metilasi DNA NGF memiliki tendensi yang rendah pada darah menstruasi wanita endometriosis sebesar 35,27%. Ekspresi relatif mRNA NGF menunjukkan tendensi peningkatan 19,229 lebih tinggi pada darah menstruasi wanita endometriosis. Tingkat metilasi DNA dan ekspresi mRNA NGF tidak menunjukkan perbedaan baik pada darah menstruasi wanita endometriosis maupun wanita tanpa endometriosis dengan nilai p > 0,05. Korelasi metilasi DNA dengan ekspresi mRNA NGF pada darah menstruasi wanita endometriosis tidak dapat dianalisis karena data yang tersedia sangat terbatas.

---

Nerve Growth Factor (NGF) is known to have higher concentrations in women with endometriosis compared to women without endometriosis. DNA methylation in the NGF promoter region is believed to cause the increase of NGF concentrations in women with endometriosis. This study is conducted to determine the correlation between DNA methylation and mRNA expression of NGF in menstrual blood of women with endometriosis. A total of 10 menstrual blood samples from women with endometriosis and women without endometriosis were used in this study. DNA methylation level of NGF was measured using Methylation-specific Polymerase Chain Reaction (MSP-PCR) and the intensity of the bands were subsequently measured using ImageJ software, while mRNA expression values of NGF ​​were measured using Quantitative Real-Time Polymerase Chain Reaction (qRT PCR). Furthermore, the correlation analysis was performed using the SPSS application. The results exhibited that the methylation level of NGF shows a low tendency in menstrual blood of women with endometriosis of 35.27%. The relative mRNA expression of NGF showed a tendency to increase 19,229-fold higher in menstrual blood of women with endometriosis. The DNA methylation level and mRNA expression of NGF showed no difference in both menstrual blood of women with endometriosis and women without endometriosis with p value > 0,05. The correlation between DNA methylation and mRNA expression of NGF in menstrual blood of women with endometriosis could not be analyzed because of very limited data."

"Latar Belakang: TNF-α dan CXCL16 terlibat dalam patofisiologi endometriosis melalui regulasi respon inflamasi dan pengkode nyeri endometriosis. Peningkatan TNF-α berperan dalam jalur pensinyalan P53 untuk apoptosis. Darah menstruasi sebagai pelepasan jaringan endometrium dapat digunakan dalam mengidentifikasi biomarker untuk diagnosis penyakit endometriosis tanpa memerlukan biopsi. Metode: Sampel darah menstruasi subjek dikumpulkan dengan menggunakan pembalut kertas saring dan jaringan endometrium dikumpulkan dengan melakukan biopsi, yang kemudian diekstraksi DNA dan RNA-nya. Tingkat metilasi DNA diukur dengan menggunakan metode pyrosequencing. Tingkat ekspresi mRNA diukur dengan menggunakan metode qPCR dan dianalisis dengan metode Livak Hasil: Ekspresi mRNA gen TNF-α pada darah menstruasi pasien endometriosis meningkat signifikan 3,73 kali lipat dibandingkan ekspresi pada kontrol (p=0,005). Gen TNF-α mengalami hipermetilasi dan berbeda bermakna dalam darah menstruasi pasien endometriosis dibandingkan kontrol (p=0,008). Sedangkan ekspresi mRNA gen CXCL16 pada darah menstruasi pasien endometriosis meningkat 2,42 kali (p=0,030) dibandingkan ekspresi mRNA darah menstruasi pada kontrol. Gen CXCL16 mengalami hipometilasi (p=0,004). Pada P53 terjadi terjadi peningkatan ekspresi gen P53 1,52 kali. Ekspresi mRNA gen TNF-α dan CXCL16 pada subjek nyeri berat lebih tinggi dibandingkan subjek nyeri sedang, dan terdapat korelasi positive. Kesimpulan: Penelitian ini menunjukkan bahwa peningkatan ekspresi mRNA TNF-α dan CXCL16 dalam darah menstruasi pasien endometriosis dapat menjadi penanda langsung untuk mendiagnosis endometriosis. Namun, untuk memvalidasi lebih lanjut temuan ini dan mengeksplorasi potensi sebagai alat diagnostik, penelitian tambahan yang melibatkan kelompok pasien yang lebih besar diperlukan

---

Background: TNF-α and CXCL16 are implicated in the pathophysiology of endometriosis through the regulation of inflammatory response and the coding of endometriosis pain. Elevated TNF-α is implicated in the P53 signaling pathway for apoptosis. Menstrual blood, as a discharge of endometrial tissue, presents an opportunity for identifying biomarkers for the diagnosis of endometriosis without resorting to biopsy. Method: Menstrual blood samples were collected using filter paper pads, and endometrial tissues were obtained via biopsy, from which DNA and RNA were extracted. DNA methylation levels were assessed using the pyrosequencing method after bisulfite conversion treatment. Meanwhile, mRNA expression levels were measured using the quantitative polymerase chain reaction (qPCR) method and analyzed using the Livak method. Results: The mRNA expression of the TNF-α gene in menstrual blood of endometriosis patients increased significantly by 3.73 times compared to controls (p=0.005). The TNF-α gene exhibited hypermethylation, significantly differing in menstrual blood of endometriosis patients compared to controls (p=0.008). The mRNA expression of the CXCL16 gene in menstrual blood of endometriosis patients increased by 2.42 times (p=0.030) compared to controls, although there was no significant difference in expression between menstrual blood and endometrial tissue in endometriosis patients (p=0.173). The CXCL16 gene displayed hypomethylation (p=0.004). There was an increase in P53 gene expression, which was 1.52 times higher than in control menstrual blood. The mRNA expression of TNF-α and CXCL16 genes in subjects experiencing severe pain was higher than in those with moderate pain, and there was a positive correlation. Conclusion: This study suggests that increased mRNA expression of TNF-α and CXCL16 in menstrual blood of endometriosis patients may serve as direct markers for diagnosing endometriosis. However, further validation of these findings and exploration of their potential as diagnostic tools requires additional studies involving larger patient cohorts."

"Metilasi DNA merupakan salah satu penyebab umum inaktivasi Mismatch Repair Gene (MMR). Gen MMR memperbaiki kesalahan penyisipan/penghapusan basa nukleotida pada proses sintesis DNA. Metilasi pada promoter gen MMR memiliki asosiasi dengan pembentukan kanker kolon, sehingga metilasi tersebut perlu diidentifikasi. Identifikasi gen MMR dapat dilakukan menggunakan teknik methylation-specific multiplex ligation-dependent probe amplification amplification (MS-MLPA). Prinsip dari teknik MS-MLPA yaitu amplifikasi probe yang menempel pada sekuens termetilasi. Tujuan dari penelitian ini yaitu untuk mengoptimasi teknik MS-MLPA dan mengidentifikasi metilasi gen MMR pada kanker kolon dengan teknik MS-MLPA. Penelitian ini menggunakan 27 sampel jaringan frozen kanker kolon yang telah tersedia di Biobank Rumah Sakit Kanker Dharmais (RSKD). Sampel tersebut dianalisis menggunakan probemix Mismatch Repair Gene [ME011-C1][C1-0518] yang telah didesain khusus untuk mendeteksi pada beberapa gen MMR yakni MLH1, PMS2, MSH6, dan MSH2. Hasil penelitian menunjukkan optimasi teknik MS-MLPA telah berhasil dilakukan, sehingga identifikasi metilasi pada gen MMR telah berhasil diperoleh pada 4 sampel pasien. Gen MMR tersebut yakni MLH1 dan MSH6, dengan persentase masing-masing 75% dan 25%.

---

DNA methylation is one of the most common causes of mismatch repair gene (MMR) inactivation. The MMR gene corrects errors in the insertion/deletion of nucleotide bases in the DNA synthesis process. MMR gene promoter methylation has an association with the formation of colon cancer, so the methylation needs to be identified. Identification of the MMR gene can be done using the methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) technique. The principle of the MS-MLPA technique is the amplification of the probe attached to the methylated sequence. The purpose of this study was to optimize the MS-MLPA technique and identify MMR gene methylation in colon cancer using the MS-MLPA technique. This study used 27 samples of frozen colon cancer tissue that were available at the Dharmais Cancer Hospital Biobank (RSKD). The samples were analyzed using the Mismatch Repair Gene probemix [ME011-C1][C1-0518] which has been specially designed to detect several MMR genes, namely MLH1, PMS2, MSH6, and MSH2. The results show that the optimization of the MS-MLPA technique has been successfully carried out, so that the identification of methylation in the MMR gene has been successfully obtained in 4 patient samples. The MMR genes are MLH1 and MSH6, with a percentage of 75% and 25%, respectively. analyzed using probemix Mismatch Repair Gene [ME011-C1][C1-0518] which has been specifically designed to detect several MMR genes namely MLH1, PMS2,

MSH6, and MSH2. The results showed that the optimization of the MS-MLPA technique was successful, so that identification of the methylation in the MMR gene was successfully obtained in 4 patient samples. The MMR genes are MLH1 and MSH6, with percentages of 75% and 25% respectively."

"Latar Belakang: Methylenetetrahydrofolate reductase (MTHFR) merupakan enzim penting untuk membentuk folat dan metabolisme methionin, sehingga enzim ini sangat dibutuhkan untuk sintesis DNA dan metilasi. Varian dari MTHFR C677T dan A1298C dapat menurunkan folat dalam plasma dan meningkatkan suseptibilitas terhadap spermatogenic arrest. Penelitian ini bertujuan untuk menganalisis polimorfisme gen MTHFR SNP A1298C dan C677T dan hubungannya dengan infertilitas pria oligozoospermia dan azoospermia di Indonesia. Metode: Penelitian ini merupakan penelitian cross sectional dengan mengambil darah 3 mL pada pria oligozoospermia dan azoospermia sejumlah 150 orang. Gen MTHFR dianalisis menggunakan teknik polymerase chain reaction (PCR) dengan primer spesifik. Penelitian dilakukan dengan teknik PCR-RFLP menggunakan enzim restriksi MboII dan HinfI. Analisis PCR-RFLP gen MTHFR digunakan untuk mendeterminasi alotip gen MTHFR SNP A1298C dan SNP C677T pada kelompok pria oligozoospermia dan azoospermia dalam populasi Indonesia. Hasil: Hasil penelitian menunjukkan bahwa distribusi alotip gen MTHFR SNP A1298C tidak berbeda bermakna (p>0,05) antara kelompok oligozoospermia dan azoospermia. Selanjutnya, distribusi alotip gen MTHFR SNP A677T antara kelompok oligozoospermia dan azoospermia juga tidak berbeda bermakna (p > 0.05). Kesimpulan: Polimorfisme gen MTHFR pada SNP A1298C dan C677T tidak berhubungan dengan infertilitas pria oligozoospermia dan azoospermia di Indonesia.

---

AbstractBackground: Methylenetetrahydrofolate reductase (MTHFR) is an important enzyme of folate and methionin metabolism, making it crucial for DNA synthesis and methylation. Variants of MTHFR C677T and A1298C gene result in reduced plasma folate levels and increase the susceptibility to spermatogenic arrest. This research aims to analyses MTHFR C677T and A1298C gene polymorphism in Indonesian infertile men with azoospermia and oligozoospermia. Methods: This cross sectional study takes 3 mL of blood from 150 infertile men with oligozoospermia and azoospermia. MTHFR gene is analyzed using polymerase chain reaction technique (PCR) with specific primers. PCR-RFLP analysis of the MTHFR gene using restriction enzymes MboII and HinfI determines allotypes, both of SNP A1298C and C677T in oligozoospermia and azoospermia in Indonesian population. Results: The results show that the distribution of allotypes of MTHFR gene SNP A1298C and A677T is not significantly different (p>0.05) between patient groups with oligozoospermia and azoospermia. Conclusion: MTHFR gene polymorphisms, both of SNP A1298C and C677T are not associated with male infertility in Indonesian men including patients with severe oligozoospermia and azoospermia."

"ABSTRAKLatar belakang: Salah satu faktor yang dicurigai berperan dalam mekanisme resisensi klopidogrel adalah faktor epigenetik seperti metilasi DNA. Individu dengan resistensi klopidogrel ini memiliki kecenderungan untuk mengalami luaran kardiovaskular yang lebih buruk. Nilai TIMI flow pasca IKPP telah diketahui berkaitan dengan luaran klinis pada pasien IMA-EST. Sampai saat ini belum ada penelitian yang menghubungan antara metilasi gen P2Y12 dengan penghambatan fungsi platelet dan nilai TIMI flow pasca IKPP pada pasien IMA EST. Tujuan: Untuk mengetahui hubungan antara metilasi gen reseptor P2Y12 terhadap fungsi penghambatan platelet dan nilai TIMI flow pasca IKPP pada pasien IMA EST. Metode: Sebanyak 118 pasien IMA-EST yang menjalani IKPP dan mendapatkan terapi klopidogrel dimasukkan kedalam populasi penelitian. Dilakukan pemeriksaan VerifyNow P2Y12 dan pemeriksaan metilasi P2Y12. Selanjutnya dilakukan analisis hubungan antara metilasi P2Y12 dengan nilai Verifynow P2Y12 dan TIMI flow pasca IKPP. Hasil: Dari seluruh subyek, 22% diantaranya termasuk klopidogrel nonresponder dan 30% memiliki nilai TIMI flow kurang dari 3. Terdapat 48% subyek yang tidak mengalami metilasi dan 19% subyek mengalami metilasi sempurna pada gen P2Y12. Tidak terdapat hubungan bermakna antara metilasi P2Y12 dengan nilai Verifynow P2Y12 dan TIMI flow pasca IKPP. Nilai Verifynow P2Y12 yang tinggi berhubungan dengan TIMI flow kurang dari 3 pasca IKPP (p=0,043). Kesimpulan: Tidak terdapat hubungan bermakna antara pola metilasi gen P2Y12 dengan penghambatan fungsi platelet dan nilai TIMI flow pasca IKPP. Pasien yangnon-responder terhadap klopidogrel berisiko untuk mendapatkan reperfusi miokard yang suboptimal.

---

ABSTRACTBackground: Mechanism of clopidogrel resistance is not well understood yet. In the other hand, epigenetic modifications such as DNA methylation, are suspected to play role in clopidogrel resistence. Subject with high on treatment clopidogrel reactivity show worsen cardiovascular outcome. Meanwhile, TIMI flow after reperfusion are known to be related with poor outcome. Study that evaluate the relationship between methylation of P2Y12 gene with Platelet Reactivity and TIMI-flow after Primary Percutaneous Coronary Intervention (PPCI) in Patients With Acute ST-segment Elevation Myocardial Infarction in South East Asia Population has never been done. Objectives: to define whether methylation of P2Y12 gene and platelet reactivity may affect the myocardial perfusion after PPCI. Methods: There were 118 of STEMI patients who underwent PPCI and had received clopidogrel were recruited for the study. We measured platelet reactivity using Verifynow P2Y12 and Methylation of P2Y12 gene. The relationship among variables are assessed using statistic method. Results: Among 118 subject, 22% are clopidogrel nonresponder and 30% had TIMI flow less than 3. Median of Methylation degree was 15% with 48% subject were unmethylated, 19% subject had 100% methylation. There are no relationship between methylation of P2Y12 gene with platelet reactivity and TIMI flow after PPCI among subjects. The value of Verifynow P2Y12 more than 208 were related TIMI flow less than 3 after PPCI (p=0,043). Conclusion: There are no relationship between methylation of P2Y12 gene with platelet reactivity and TIMI flow after PPCI among subjects. Clopidogel nonresponder subjects were more likely to have suboptimal reperfusion after PPCI"

"Latar belakang: Resistensi klopidogrel merupakan salah satu faktor risiko penting terjadinya kejadian iskemik berulang pada pasien yang telah mendapat terapi anti platelet yang optimal. Penelitian ini bertujuan untuk mengetahui peran metilasi DNA gen CYP2C19 sebagai salah satu faktor epigenetik terhadap kejadian resistensi klopidogrel pada pasien infark miokard akut dengan elevasi segmen ST (IMA-EST) yang menjalani intervensi koroner perkutan primer (IKPP).Metode: Pasien IMA-EST yang menjalani IKPP diberikan antiplatelet klopidogrel dan menjalani pemeriksaan fungsi platelet degan VerifyNowTM. Kriteria untuk mendefinisikan resistensi klopidogrel adalah nilai PRU >208. Pemeriksaan metilasi DNA gen CYP2C19 dilakukan dengan metode bisulfite genomic sequencing technology. Data klinis, laboratorium, dan angiografik termasuk TIMI flow dikumpulkan untuk dilakukan analisis.Hasil: Dari 122 subjek, resistensi klopidogrel ditemukan pada 22% subjek. Kelompok dengan presentase metilasi DNA <50% mempunyai risiko lebih tinggi terjadinya resistensi klopidogrel (OR 4.5 IK95% 2.1-9.3, nilai p 0.018). Grup ini juga diketahui mempunyai TIMI flow post-IKPP yang suboptimal (OR 3.4 IK95% 1.3 - 8.7, nilai p 0.045).Kesimpulan: Hipometilasi DNA gen CYP2C19 meningkatkan risiko terjadinya resistensi klopidogrel dan luaran klinis yang lebih buruk.

---

Background: Clopidogrel resistance is an important risk factor of recurrence of ischemic event after optimal antiplatelet therapy. We aimed to investigate the role of DNA methylation of CYP2C19 gene as one of epigenetic factor to the risk of clopidogrel resistance in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PPCI).

Methods: STEMI patients undergoing PPCI were pretreated with clopidogrel, and their platelet function was measured using VerifyNowTM assay. The criteria for high on- treatment platelet reactivity (HPR) was defined according to the expert consensus criteria (PRU >208). DNA methylation of the CYP2C19 gene was performed using bisulfite genomic sequencing technology. Furthermore, clinical, laboratory and angiographic data including TIMI flow were collected.

Result: Among 122 patients, clopidogrel resistance was found in 22% patients. After dividing into two groups, methylation <50% was associated with increased risk of clopidogrel resistance (OR 4.5 95%CI 2.1-9.3, P value 0.018). This group also found to have suboptimal post-PCI TIMI flow (OR 3.4 95%CI 1.3 - 8.7, P value 0.045).

Conclusions: The lower DNA methylation level of the CYP2C19 gene increases the risk of clopidogrel resistance and subsequent poorer clinical outcome."

"Sindrom Ovarium Polikistik (SOPK) didefinisikan sebagai kelainan hormonal multifaktorial yang ditandai dengan berlebihnya jumlah hormon androgen, menstruasi yang irregular dan atau morfologi ovarium yang berukuran besar serta berkista-kista. SOPK dapat berujung pada berbagai komplikasi, seperti penyakit kardiovaskular, resistensi insulin, serta infertilitas. Studi-studi sebelumnya menunjukkan bahwa patogenesis SOPK dapat berkaitan dengan faktor genetik, non-genetik, maupun epigenetik. Salah satu faktor epigenetik yang diduga berperan adalah metilasi dari DNA gen Anti-Mulerian Hormone (AMH). Gen AMH menghasilkan suatu produk berupa hormon, yakni hormon AMH yang terbukti ditemukan meningkat secara signifikan pada serum pasien SOPK. Untuk mengevaluasi peranan faktor epigenetik berupa metilasi DNA gen AMH pada patogenesis SOPK, dilakukan suatu penelitian potong lintang menggunakan sampel dari jaringan granulosa ovarium. Sampel diperoleh dari 14 wanita dengan SOPK dan 9 kontrol. DNA dari sampel diisolasi untuk kemudian dikonversi bisulfit dan diamplifikasi menggunakan metode Methyl Specific PCR (MSP). Hasil amplifikasi kemudian diamati dengan menggunakan gel elektroforesis dan intensitas pita yang tampak dibawah sinar ultraviolet dikuantifikasi dengan cara konversi kedalam bentuk numerik menggunakan perangkat lunak ImageJ. Data yang diperoleh dianalisis secara statistik menggunakan uji Mann-Whitney dengan signifikansi ditetapkan apabila p<0.05. Dari hasil analisis ditemukan perbedaan yang signifikan antara persentase metilasi DNA pada pasien SOPK dengan kontrol (p=0.002), dimana pasien SOPK cenderung memiliki tingkat metilasi DNA gen AMH yang lebih rendah dibandingkan dengan kontrol. Hasil tersebut mengindikasikan bahwa rendahnya tingkat metilasi DNA gen AMH pada pasien SOPK dapat meningkatkan ekspresi dan produksi AMH. Peningkatan AMH tersebut diduga berkontribusi dalam patogenesis SOPK.

---

Polycystic Ovarian Syndrome (PCOS) defined as a multifactorial hormonal disorder that is characterized by androgen excess, irregular periods, and or enlarged ovarium with cystics morfology. PCOS leads to many complications, such as cardiovascular disease, insulin resistance, and infertility. Previous studies showed that the pathogenesis of PCOS correlated with genetic, non-genetic, and epigenetic factors. One of epigenetic factors that is suspected to play a role is the DNA methylation of Anti-Mullerian Hormone (AMH) gene. AMH gene produces a hormone, called AMH, of which found to elevate in the serum of PCOS patient. To evaluate the contribution of AMH gene DNA methylation in the pathogenesis of PCOS, this cross-sectional study using ovarian granulose cells sample was performed. Samples were obtained from 14 PCOS patient and 9 control. The DNA from each sample was isolated, converted by bisulfite conversion, and amplificated by Methyl Specific PCR (MSP) method. After being amplificated, samples then were observed by using electrophoresis gel and the band intensity that was appeared under ultraviolet was quantified by conversion to numeric form by using ImageJ software. The obtained data statistically analyzed by Mann-Whitney test with significant result considered to p<0.05. The analysis result showed that there was a significant difference between DNA methylation percentage in PCOS group and control group (P=0.002), of which PCOS patient tend to have a lower AMH gene DNA methylation compared to control. This finding indicates that the lower AMH gene DNA methylation in PCOS patient may increase the expression and production of AMH. This elevation of AMH suspected to play a role in the pathogenesis of PCOS."